Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-16 | "In his 19 years of pharma experience, he has held line management roles in commercial, manufacturing and IT and the office of the CEO... Mr. Baxter was educated at Thames Valley University and is a Fellow of the Chartered Institute of Management Accountants (FCMA)." |
| 2016-04-12 | "Mr. Baxter has served as President and CEO and a Director of VBI Vaccines, Inc.... Previously, he was managing partner for the venture capital firm, The Column Group..." |
| 2017-05-01 | "Mr. Baxter has served as President and CEO... Previously, he was managing partner for the venture capital firm... He also chaired GSK's R&D Operating Board." |
| 2017-06-20 | "Jeff Baxter (11)" |
| 2018-04-27 | "Mr. Baxter was educated at Thames Valley University and is a Fellow of the Chartered Institute of Management Accountants (FCMA)." |
| 2019-04-23 | "Mr. Baxter has more than 25 years of diverse experience in corporate finance... The Nominating and Corporate Governance Committee believes that Mr. Baxter’s past experience in the pharmaceutical industry bring financial expertise, industry knowledge, and research and development experience to the Board." |
| 2020-04-21 | "Mr. Baxter was educated at Thames Valley University and is a Fellow of the Chartered Institute of Management Accountants." |
| 2021-04-21 | "Mr. Baxter has served as President and CEO... Previously, he was managing partner for the venture capital firm... Mr. Baxter was educated at Thames Valley University and is a Fellow of the Chartered Institute of Management Accountants." |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-09